Recent Searches
As a manager in Strategy and Execution at EY-Parthenon, Amir leads engagements across the biopharma and MedTech sectors, advising clients on growth strategy, commercial due diligence and operating model transformation.
Amir has supported a broad range of clients, from pre‑commercial startups to large global organizations, across therapeutic areas including cardiovascular, neurology, orthopedics, metabolic and consumer health; and across geographies spanning the US, EU5 and beyond.
Prior to EY‑Parthenon, Amir served as a postdoctoral scholar and senior researcher at California Institute of Technology (Caltech). He holds a PhD in Mechanical Engineering from UCLA, where he received the Outstanding Student Award, and a BS in Mechanical Engineering from Sharif University of Technology.
His research has been published in leading journals including Nature, Science, Current Biology, IEEE and ASME, and he has secured over $1 million in funding as a principal investigator.
Amir is shaping the future with confidence by helping biopharma and MedTech organizations make rigorous, evidence‑based decisions that turn scientific innovation into real‑world impact. Through his work, he supports clients in prioritizing investments, improving execution and bringing clarity to complex strategic choices that improve patient outcomes. He is committed to developing high‑performing teams and fostering a culture of analytical rigor and intellectual curiosity. By combining deep scientific understanding with disciplined strategy and execution, Amir helps organizations make more confident decisions and create long‑term value across the health ecosystem.
